Forecast

Buy	0
Hold	0
Sell	1

News Go to news feed

Corbion cuts adjusted EBITDA margin guidance and shares fall sharply

Corbion lowered its forecast for the adjusted EBITDA margin for 2026 to above 16% (previously around 17%), sending the share price down about 3.8%. Management cited macroeconomic uncertainty and unexpected cost inflation from the Middle East conflict (commodity prices, freight rates, energy costs) as reasons. The revenue growth target (organic 3–6%) and free cash flow (€85–90m) remained unchanged, but weak cash generation in Q2 and a working-capital outflow amplified the market reaction. Analysts viewed the margin revision as negative and the share move as company-specific rather than market-wide. » More on de.investing.com
Corbion Q1 2026: revenue stable, margins under pressure and stock falls

Corbion reported Q1 2026 revenue of €294 million and adjusted EBITDA of €37.8 million (margin 12.9%). The stock fell 6.08% to €19.24 after the figures. The Functional Ingredients & Solutions segment is under margin pressure, while Health & Nutrition benefits from robust demand. Free cash flow was seasonally at -€15.7 million; management confirms full-year FCF of €85–90 million and expects near-term improvements from cost reductions. » More on de.investing.com
Corbion: undiluted earnings per share in 2025 rise 63% to €1.29 thanks to margin expansion

Corbion reports undiluted earnings per share of €1.29 for 2025 (+63.3%), driven by a significant expansion in margins; net revenue was €1,267.4m, adjusted EBITDA €204.3m (margin 16.1%, +250 basis points). In Q4, volume and mix growth and organic adjusted EBITDA accelerated, and free cash flow for the year amounted to €90.8m. The board proposes a total distribution of €1.00 per share (€0.64 regular, €0.36 special dividend); net debt fell to 1.5x EBITDA. For 2026 Corbion expects organic revenue growth of 3–6%, an adjusted EBITDA margin of around 17% and free cash flow of €85–90m; in the short term Q1 2026 is likely to be below the strong prior year, and negative currency effects weighed on the market reaction. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Corbion has already paid 1,00€ in dividends. The last payout was in May.

Financials

In the last quarter, Corbion had revenue of 631,10 Mio€ and net profit of 29,80 Mio€

(EUR)	Jun 2026	YoY
Revenue	+631,10 Mio	-
Gross profit	+154,30 Mio	-
Net profit	+29,80 Mio	-
EBITDA	+85,00 Mio	-

Fundamentals

Metric	Value
Market capitalization	+1,14 Mrd€
Number of shares	57,63 Mio
52-week high/low	+21,96€ - +16,16€
Dividend yield	+5,00%
Dividends TTM	+1,00€
Beta	0,93
P/E ratio	+18,31
PEG ratio	−2,16
P/B ratio	+1,51
P/S ratio	+0,91

Company profile

Corbion N.V. liefert weltweit Milchsäure und Milchsäurederivate, Emulgatoren, funktionelle Enzymmischungen, Mineralien, Vitamine und Algeninhaltsstoffe. Das Unternehmen bietet Inhaltsstofflösungen aus erneuerbaren Ressourcen für die Märkte Lebensmittel, Haushalts- und Körperpflegeprodukte, Pharmazeutika, Tiernahrung, medizinische Geräte und Biokunststoffe an. Es vermarktet seine Produkte über ein Netz von Verkaufsbüros und Händlern. Das Unternehmen war früher als CSM N.V. bekannt und änderte im Oktober 2013 seinen Namen in Corbion N.V.. Corbion N.V. wurde 1919 gegründet und hat seinen Hauptsitz in Amsterdam, Niederlande.